Phase 2 Clinical Trial of Ciliary Neurotrophic Factor (CNTF) for Macular Telangiectasia Type 2 (MacTel) (14-EI-0078, 17-EI-0136)

$73,122ZIAFY2020EYNIH

National Eye Institute

Investigators

Henry Wileycontact

Linked publications, trials & patents

Paper 36846105 Paper 34389818 Paper 33229343 Paper 32586743 Paper 32152145 Paper 30292541

View original record on NIH RePORTER →

Phase 2 Clinical Trial of Ciliary Neurotrophic Factor (CNTF) for Macular Telangiectasia Type 2 (MacTel) (14-EI-0078, 17-EI-0136) · GrantIndex